Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events

🤖 AI Analyzed

Recent

📄 Page 96 of 98

BERKLEY W R CORP

8-K December 5, 2025

Key Highlights

Mitsui Sumitomo Insurance Co., Ltd. (MSI) acquired at least 12.5% of BERKLEY W R...
The shares were purchased from the Berkley family and their trusts as part of pr...
This significant stake by a major international insurer could signal a strategic...

Read Analysis

🤖 AI Generated

PharmaCyte Biotech, Inc.

8-K December 5, 2025

Key Highlights

PharmaCyte Biotech received an official notice from Nasdaq for failing to meet t...
The company's common stock closed below $1.00 per share for 30 consecutive busin...
PharmaCyte has 180 calendar days, until June 1, 2026, to regain compliance by ha...

Read Analysis

🤖 AI Generated

OPGEN INC

8-K December 5, 2025

Key Highlights

OPGEN INC executed a reverse stock split to meet NASDAQ listing requirements and...
John Tan Honjian stepped down as CEO on December 1, 2025, but will continue as C...
Christian-Laurent Bonte was appointed as the new CEO on December 1, 2025, bringi...

Read Analysis

🤖 AI Generated

aTYR PHARMA INC

8-K December 5, 2025

Key Highlights

aTYR PHARMA INC received a deficiency notice from Nasdaq for failing to maintain...
The company's stock price closed below $1.00 for 30 consecutive business days, v...
This puts aTYR PHARMA at significant risk of being delisted from The Nasdaq Capi...

Read Analysis

🤖 AI Generated

PROS Holdings, Inc.

8-K December 5, 2025

Key Highlights

PROS Holdings stockholders overwhelmingly approved the company's acquisition and...
PROS will no longer be a publicly traded company, marking a massive change in it...
The decision was made at a special meeting of stockholders on December 4, 2025, ...

Read Analysis

🤖 AI Generated

OCULAR THERAPEUTIX, INC

8-K December 5, 2025

Key Highlights

OCULAR THERAPEUTIX, INC. filed an official report detailing its plans and signif...
AXPAXLI is a crucial product for treating wet age-related macular degeneration (...
The filing explicitly highlights major regulatory risks, including potential FDA...

Read Analysis

🤖 AI Generated

XWELL, Inc.

8-K December 5, 2025

Key Highlights

XWELL, Inc. received a warning letter from Nasdaq for failing to maintain a mini...
The company's stock price closed below $1.00 for 30 consecutive business days, f...
XWELL faces potential delisting from Nasdaq if it cannot regain compliance withi...

Read Analysis

🤖 AI Generated

Warner Bros. Discovery, Inc.

8-K December 5, 2025

Key Highlights

Netflix is acquiring Warner Bros.' entire film and television studios, including...
The massive deal is valued at approximately $82.7 billion (total) with an equity...
The acquisition is expected to close in Q3 2026, after WBD first separates its G...

Read Analysis

🤖 AI Generated

Carisma Therapeutics Inc.

8-K December 5, 2025

Key Highlights

Carisma Therapeutics Inc. is voluntarily delisting its stock from the Nasdaq exc...
The company plans to stop filing regular financial reports with the SEC.
Executive Natalie McAndrew resigned from her position.

Read Analysis

🤖 AI Generated

Ubiquiti Inc.

8-K December 5, 2025

Key Highlights

Ubiquiti board member Ronald A. Sege passed away unexpectedly on November 30, 20...
His passing caused Ubiquiti to fall out of compliance with NYSE rules regarding ...
Mr. Sege was posthumously re-elected as a Class II director at the Annual Meetin...

Read Analysis

🤖 AI Generated

CIMG Inc.

8-K December 5, 2025

Key Highlights

CIMG Inc. completed a 1-for-20 reverse stock split, exchanging 20 old shares for...
The split reduced the total number of outstanding shares from approximately 309....
The primary goal is to increase the stock price per share, aiming to meet Nasdaq...

Read Analysis

🤖 AI Generated

INTENSITY THERAPEUTICS, INC.

8-K December 5, 2025

Key Highlights

INTENSITY THERAPEUTICS, INC. received an extension from Nasdaq to regain complia...
The company's stock price has been trading below $1.00 per share, violating Nasd...
They now have until June 1, 2026, to get their stock price consistently above $1...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage